a public good project by the
Synthesis
Company
of California

© 2026

Scott C. Bell | doi.page

0 works0 citations0 h-index

Scott C. Bell

Griffith University(AU)Gold Coast Hospital(AU)

Publications by Year

Research Areas

Cystic Fibrosis Research Advances, Tracheal and airway disorders, Bacterial biofilms and quorum sensing, Neonatal Respiratory Health Research, Antibiotic Resistance in Bacteria

Most-Cited Works

→ A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation(2011)2,161 cited
→ ECFS best practice guidelines: the 2018 revision(2018)750 cited
→ Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals(2018)712 cited
→ European Cystic Fibrosis Society Standards of Care: Best Practice guidelines(2014)588 cited
→ Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium(2016)579 cited
→ Cystic fibrosis(2015)523 cited

→ The Rise of Non-Tuberculosis Mycobacterial Lung Disease(2020)

461 cited

→ A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial(2014)438 cited

→ Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease(1999)330 cited

→ Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals(2020)280 cited